Pharma — Takeda's Qdenga vaccine emerges as new option for dengue prevention

The Qdenga vaccine, developed by Takeda, offers a new preventative measure against dengue fever, a significant health issue in tropical regions. The live-attenuated vaccine, which has already received approval in over 30 countries including the EU and Brazil, could be a critical tool for nations like India with a high disease burden. India recently reported over 321,000 dengue cases in a single year.